apomorphine has been researched along with arginine in 16 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (6.25) | 18.7374 |
| 1990's | 3 (18.75) | 18.2507 |
| 2000's | 7 (43.75) | 29.6817 |
| 2010's | 4 (25.00) | 24.3611 |
| 2020's | 1 (6.25) | 2.80 |
| Authors | Studies |
|---|---|
| Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Botalla, L; Chiodini, PG; Cremascoli, G; Liuzzi, A; Silvestrini, F | 1 |
| Argiolas, A; Melis, MR | 1 |
| Argiolas, A | 1 |
| Argiolas, A; Melis, MR; Stancampiano, R | 1 |
| Harro, J; Kask, A | 1 |
| Battisti, JJ; Shreffler, CB; Uretsky, NJ; Wallace, LJ | 1 |
| Hu, XQ; Stewart, RR; Weight, FF; Zhang, L | 1 |
| Mokri, A; Nojoomi, K; Sharifzadeh, M; Zarrindast, MR | 1 |
| Kiagiadaki, F; Koulakis, E; Thermos, K | 1 |
| Cho, EY; Kim, JH; Kim, KM; Min, C; Park, JH | 1 |
| Andreatini, R; Chioca, LR; Correia, D; Pereira, M; Pizzolatti, MG; Santos, AR; Siba, IP; Vital, MA | 1 |
| Brito, BM; Gobira, PH; Joca, SRL; Sartim, AG | 1 |
| Balenovic, I; Blagaic, AB; Cilic, M; Drmic, D; Filipcic, I; Ilic, S; Kokot, A; Seiwerth, S; Sikiric, P; Strbe, S; Tvrdeic, A; Vukojevic, J; Zemba Cilic, A; Zemba, M; Zoricic, Z | 1 |
1 review(s) available for apomorphine and arginine
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
1 trial(s) available for apomorphine and arginine
| Article | Year |
|---|---|
Inhibitory effect of dopaminergic stimulation on GH release in acromegaly.
Topics: Acromegaly; Adult; Apomorphine; Arginine; Carboxy-Lyases; Dihydroxyphenylalanine; Female; Glucose; Growth Hormone; Humans; Insulin; Male; Middle Aged; Placebos; Time Factors | 1974 |
14 other study(ies) available for apomorphine and arginine
| Article | Year |
|---|---|
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Nitric oxide synthase inhibitors prevent apomorphine- and oxytocin-induced penile erection and yawning in male rats.
Topics: Amino Acid Oxidoreductases; Animals; Apomorphine; Arginine; Cerebral Ventricles; Dose-Response Relationship, Drug; Injections, Intravenous; Injections, Intraventricular; Male; Nitric Oxide Synthase; omega-N-Methylarginine; Oxytocin; Penile Erection; Rats; Rats, Sprague-Dawley; Stereoisomerism; Stereotaxic Techniques; Yawning | 1993 |
Nitric oxide is a central mediator of penile erection.
Topics: Animals; Apomorphine; Arginine; Dose-Response Relationship, Drug; Injections; Injections, Intraventricular; Male; Methylene Blue; N-Methylaspartate; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitroglycerin; Oxytocin; Paraventricular Hypothalamic Nucleus; Penile Erection; Rats; Rats, Sprague-Dawley | 1994 |
Prevention by NG-nitro-L-arginine methyl ester of apomorphine- and oxytocin-induced penile erection and yawning: site of action in the brain.
Topics: Animals; Apomorphine; Arginine; Brain; Dose-Response Relationship, Drug; Guanylate Cyclase; Injections, Intraventricular; Male; Methylene Blue; Microinjections; NG-Nitroarginine Methyl Ester; Nitric Oxide; Oxytocin; Penile Erection; Rats; Rats, Sprague-Dawley; Yawning | 1994 |
Inhibition of amphetamine- and apomorphine-induced behavioural effects by neuropeptide Y Y(1) receptor antagonist BIBO 3304.
Topics: Aggression; Amphetamine; Animals; Apomorphine; Arginine; Behavior, Animal; Central Nervous System Stimulants; Dopamine Agonists; Injections, Intraventricular; Injections, Subcutaneous; Male; Microinjections; Motor Activity; Rats; Rats, Wistar; Receptors, Neuropeptide Y | 2000 |
NMDA antagonists block expression of sensitization of amphetamine- and apomorphine-induced stereotypy.
Topics: Amphetamine; Animals; Apomorphine; Arginine; Behavior, Animal; Dizocilpine Maleate; Enzyme Inhibitors; Excitatory Amino Acid Antagonists; Indazoles; Male; Mice; Nitric Oxide Synthase; Piperazines; Receptors, N-Methyl-D-Aspartate; Stereotyped Behavior | 2000 |
Arginine 222 in the pre-transmembrane domain 1 of 5-HT3A receptors links agonist binding to channel gating.
Topics: Amino Acid Sequence; Animals; Apomorphine; Arginine; Cell Line; Electrophysiology; Humans; Ion Channel Gating; Kinetics; Mice; Mutagenesis, Site-Directed; Point Mutation; Protein Structure, Tertiary; Receptors, Serotonin, 5-HT3; Serotonin; Serotonin 5-HT3 Receptor Agonists; Transfection | 2003 |
Nitric oxide agents and apomorphine-induced rat behaviors.
Topics: Animals; Apomorphine; Arginine; Behavior, Animal; Dopamine Agonists; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Rats; Rats, Wistar | 2004 |
Dopamine (D1) receptor activation and nitrinergic agents influence somatostatin levels in rat retina.
Topics: Animals; Apomorphine; Arginine; Cyclic GMP; Dopamine; Dopamine Agonists; Dose-Response Relationship, Drug; Female; Nitric Oxide; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D1; Retina; Somatostatin; Tissue Culture Techniques | 2008 |
Characterization of functional roles of DRY motif in the 2nd intracellular loop of dopamine D2 and D3 receptors.
Topics: Amino Acid Motifs; Apomorphine; Arginine; Aspartic Acid; Cell Line; Cell Membrane; Cyclic AMP; Dopamine Agonists; Dopamine Antagonists; Dose-Response Relationship, Drug; Humans; Mutation; Protein Conformation; Protein Structure, Tertiary; Protein Transport; Quinpirole; Receptors, Dopamine D2; Receptors, Dopamine D3; Signal Transduction; Spiperone; Sulpiride; Transfection | 2008 |
Myricitrin, a nitric oxide and protein kinase C inhibitor, exerts antipsychotic-like effects in animal models.
Topics: Animals; Antipsychotic Agents; Apomorphine; Arginine; Catalepsy; Disease Models, Animal; Dopamine Agonists; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Flavonoids; Indazoles; Male; Mice; Motor Activity; Nitric Oxide; Phytotherapy; Plant Leaves; Plant Preparations; Protein Kinase C; Psychotic Disorders; Rats; Rats, Wistar; Stereotyped Behavior; Syzygium; Tamoxifen | 2011 |
Attenuation of glutamatergic and nitrergic system contributes to the antidepressant-like effect induced by capsazepine in the forced swimming test.
Topics: 2-Amino-5-phosphonovalerate; Animals; Antidepressive Agents; Apomorphine; Arginine; Capsaicin; Cyclic GMP; Depression; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Administration Routes; Enzyme Inhibitors; Exploratory Behavior; Glutamic Acid; Male; Microinjections; Nitric Oxide; Nitroprusside; Rats; Receptors, N-Methyl-D-Aspartate; Statistics, Nonparametric; Swimming | 2019 |
Pentadecapeptide BPC 157 counteracts L-NAME-induced catalepsy. BPC 157, L-NAME, L-arginine, NO-relation, in the suited rat acute and chronic models resembling 'positive-like' symptoms of schizophrenia.
Topics: Amphetamine; Animals; Apomorphine; Arginine; Behavior, Animal; Catalepsy; Disease Models, Animal; Dizocilpine Maleate; Dopamine Agents; Enzyme Inhibitors; Haloperidol; Male; Neuroprotective Agents; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Peptide Fragments; Proteins; Rats; Rats, Wistar; Schizophrenia | 2021 |